Potentiation of ryanodine receptor–mediated calcium release by MAPK is responsible for epidermal transformation and carcinogenesis
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2505055122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Pengcheng Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, Pomona, CA 91766. Hauptthemen laut MEDLINE: Ryanodine Receptor Calcium Release Channel, Calcium, Epidermis, Carcinogenesis. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | NCI | Division of Cancer Prevention, National Cancer Institute (DCP, NCI), NCI NIH HHS.
Abstract (Originalsprache)
Epidermal growth factor (EGF) induces anchorage-independent growth in promotion-sensitive (P + ) mouse epidermal cell model JB6 primarily through activation of the MAPK/ERK signaling pathway. The β-blocker carvedilol inhibits EGF-promoted JB6 transformation, but the underlying mechanism is unknown. Since carvedilol suppresses overactivated ryanodine receptors (RyRs) independently of its adrenergic blocking effects, we hypothesized that EGF-promoted transformation requires RyR-mediated calcium (Ca 2+ ) release and that carvedilol inhibits transformation via targeting RyRs. All RyR subtypes were present in epidermis and strongly upregulated by ultraviolet (UV) radiation, as demonstrated in an RyR2-tdTomato reporter mouse model. In vitro, EGF induced ERK phosphorylation and RyR2 upregulation and increased RyR agonist 4-chloro-m-cresol (4-CMC)-evoked Ca 2+ release, which is inhibitable by structurally divergent RyR stabilizers and inhibitors of MAPK and PLC, but not by most β-blockers. Expression of constitutively active K-RAS and MEK-1 or UV also potentiated 4-CMC-evoked Ca 2+ release. RyR agonists and the Ca 2+ ionophore ionomycin promoted JB6 transformation while RyR stabilizers, the intracellular Ca 2+ chelator BAPTA/AM, and inhibitors of MAPK and PLC blocked transformation. The RyR shRNAs abolished the transformation-inhibitory effect of carvedilol. The IC 50 values of five carvedilol derivatives for suppressing RyR-mediated Ca 2+ release positively correlated with the IC 50 values for transformation inhibition. In vivo, UV-induced DNA damage and skin inflammation were enhanced by topical 4-CMC treatment but attenuated in the RyR2-E4872Q knock-in mice in which RyR2 activity is reduced. Human skin tissue microarray analysis confirmed spatial colocalization of phospho-ERK and RyR2 in the same tumor areas. Thus, potentiation of RyR-mediated Ca 2+ release by MAPK is an important pathway leading to carcinogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology and Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, Pomona, CA 91766.
- Department of Stomatology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
- Department of Pharmaceutical Sciences, Marshall B. Ketchum University, Fullerton, CA 92831.
- Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, CA 92618.
- Libin Cardiovascular Institute, Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
- Department of Chemistry, University of Calgary, Calgary, AB T2N 1N4, Canada.
ORCID-Profile: Pengcheng Wang, Chathurika Rathnayaka, Zhenpeng Song, Thomas G Back, S R Wayne Chen, Ying Huang
Förderung
- HHS | NIH | NCI | Division of Cancer Prevention, National Cancer Institute (DCP, NCI)
- NCI NIH HHS
Zitieren
APA
Wang, P., Cleveland, K. H., Shahid, A., Rathnayaka, C., Amirrad, F., Song, Z., Estillore, J. P., Wang, R., Back, T. G., Chen, S. R. W., & Huang, Y. (2025). Potentiation of ryanodine receptor–mediated calcium release by MAPK is responsible for epidermal transformation and carcinogenesis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2505055122
Vancouver
Wang P, Cleveland KH, Shahid A, Rathnayaka C, Amirrad F, Song Z, et al. Potentiation of ryanodine receptor–mediated calcium release by MAPK is responsible for epidermal transformation and carcinogenesis. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2505055122
BibTeX
@article{Wang2025,
author = {Wang, Pengcheng and Cleveland, Kristan H and Shahid, Ayaz and Rathnayaka, Chathurika and Amirrad, Farideh and Song, Zhenpeng and Estillore, John Paul and Wang, Ruiwu and Back, Thomas G and Chen, S R Wayne and Huang, Ying},
title = {Potentiation of ryanodine receptor–mediated calcium release by MAPK is responsible for epidermal transformation and carcinogenesis},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2505055122}
}
EUVIMED